Catalio Capital Management, LP Eli Lilly & CO Transaction History
Catalio Capital Management, LP
- $411 Billion
- Q1 2025
A detailed history of Catalio Capital Management, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Catalio Capital Management, LP holds 23,682 shares of LLY stock, worth $17.9 Million. This represents 4.76% of its overall portfolio holdings.
Number of Shares
23,682Holding current value
$17.9 Million% of portfolio
4.76%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
4,380Shares Held
822MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$76.7 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$72.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$60 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.9 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$26.1 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $720B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...